INNV Quote, Financials, Valuation and Earnings

Astrana Health has a net margin of -2.4% compared to InnovAge Holding's net margin of 3.36%. InnovAge Holding's return on equity of -5.29% beat Astrana Health's return on equity of 12.67%.

InnovAge Holding has a consensus price target of $5.50, signalling upside risk potential of 31.27%. On the other hand Astrana Health has an analysts' consensus of $64.5000 which suggests that it could grow by 91.4%. Given that Astrana Health has higher upside potential than InnovAge Holding, analysts believe Astrana Health is more attractive than InnovAge Holding.

InnovAge Holding has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Astrana Health has a beta of 1.134, suggesting its more volatile than the S&P 500 by 13.363%.

InnovAge Holding has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Astrana Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InnovAge Holding pays -- of its earnings as a dividend. Astrana Health pays out 102.24% of its earnings as a dividend.

InnovAge Holding quarterly revenues are $205.1M, which are smaller than Astrana Health quarterly revenues of $478.7M. InnovAge Holding's net income of -$4.9M is lower than Astrana Health's net income of $16.1M. Notably, InnovAge Holding's price-to-earnings ratio is -- while Astrana Health's PE ratio is 25.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InnovAge Holding is 0.72x versus 0.93x for Astrana Health. Usually stocks with elevated PS ratios are considered overvalued.

Humana has a net margin of -2.4% compared to InnovAge Holding's net margin of 1.63%. InnovAge Holding's return on equity of -5.29% beat Humana's return on equity of 8.1%.

InnovAge Holding has a consensus price target of $5.50, signalling upside risk potential of 31.27%. On the other hand Humana has an analysts' consensus of $287.90 which suggests that it could grow by 16.51%. Given that InnovAge Holding has higher upside potential than Humana, analysts believe InnovAge Holding is more attractive than Humana.

InnovAge Holding has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Humana has a beta of 0.532, suggesting its less volatile than the S&P 500 by 46.758%.

InnovAge Holding has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana offers a yield of 1.43% to investors and pays a quarterly dividend of $0.89 per share. InnovAge Holding pays -- of its earnings as a dividend. Humana pays out 17.32% of its earnings as a dividend. Humana's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

InnovAge Holding quarterly revenues are $205.1M, which are smaller than Humana quarterly revenues of $29.4B. InnovAge Holding's net income of -$4.9M is lower than Humana's net income of $480M. Notably, InnovAge Holding's price-to-earnings ratio is -- while Humana's PE ratio is 21.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InnovAge Holding is 0.72x versus 0.26x for Humana. Usually stocks with elevated PS ratios are considered overvalued.

National Healthcare has a net margin of -2.4% compared to InnovAge Holding's net margin of 12.58%. InnovAge Holding's return on equity of -5.29% beat National Healthcare's return on equity of 13.34%.

InnovAge Holding has a consensus price target of $5.50, signalling upside risk potential of 31.27%. On the other hand National Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that InnovAge Holding has higher upside potential than National Healthcare, analysts believe InnovAge Holding is more attractive than National Healthcare.

InnovAge Holding has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Healthcare has a beta of 0.427, suggesting its less volatile than the S&P 500 by 57.321%.

InnovAge Holding has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Healthcare offers a yield of 2.15% to investors and pays a quarterly dividend of $0.61 per share. InnovAge Holding pays -- of its earnings as a dividend. National Healthcare pays out 53.24% of its earnings as a dividend. National Healthcare's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

InnovAge Holding quarterly revenues are $205.1M, which are smaller than National Healthcare quarterly revenues of $340.2M. InnovAge Holding's net income of -$4.9M is lower than National Healthcare's net income of $42.8M. Notably, InnovAge Holding's price-to-earnings ratio is -- while National Healthcare's PE ratio is 14.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InnovAge Holding is 0.72x versus 1.42x for National Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Sonida Senior Living has a net margin of -2.4% compared to InnovAge Holding's net margin of -18.41%. InnovAge Holding's return on equity of -5.29% beat Sonida Senior Living's return on equity of -145.3%.

InnovAge Holding has a consensus price target of $5.50, signalling upside risk potential of 31.27%. On the other hand Sonida Senior Living has an analysts' consensus of -- which suggests that it could grow by 5.49%. Given that InnovAge Holding has higher upside potential than Sonida Senior Living, analysts believe InnovAge Holding is more attractive than Sonida Senior Living.

InnovAge Holding has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sonida Senior Living has a beta of 1.798, suggesting its more volatile than the S&P 500 by 79.772%.

InnovAge Holding has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonida Senior Living offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InnovAge Holding pays -- of its earnings as a dividend. Sonida Senior Living pays out -- of its earnings as a dividend.

InnovAge Holding quarterly revenues are $205.1M, which are larger than Sonida Senior Living quarterly revenues of $74.8M. InnovAge Holding's net income of -$4.9M is higher than Sonida Senior Living's net income of -$13.8M. Notably, InnovAge Holding's price-to-earnings ratio is -- while Sonida Senior Living's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InnovAge Holding is 0.72x versus 0.99x for Sonida Senior Living. Usually stocks with elevated PS ratios are considered overvalued.